
Quidel Corporation QDEL
$ 11.26
-1.14%
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
42.1 M |
Market Cap[1] |
$ 474 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Co-Diagnostics
CODX
|
$ 1.48 | -9.51 % | $ 1.97 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 18.95 | 0.4 % | $ 549 M | Nasdaq Global Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 15.85 | -2.1 % | $ 479 M | Nasdaq Global Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 18.56 | - | $ 196 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 112.0 | -1.1 % | $ 34 B | NYSE,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.8 | -5.26 % | $ 7.96 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 20.15 | -1.66 % | $ 1.07 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 95.11 | -1.61 % | $ 6.42 B | Nasdaq Global Select Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Medpace Holdings
MEDP
|
$ 417.38 | -0.43 % | $ 12 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 036.33 | -0.53 % | $ 21.4 B | NYSE,SPB | ||
|
Myriad Genetics
MYGN
|
$ 3.63 | 0.14 % | $ 336 M | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
NeoGenomics
NEO
|
$ 8.31 | -0.6 % | $ 1.06 B | Nasdaq Global Select Market,SPB | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 158.4 | -0.56 % | $ 7.85 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
National Research Corporation
NRC
|
$ 18.87 | -0.3 % | $ 422 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 191.02 | -2.99 % | $ 18.8 B | Nasdaq Global Select Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Koninklijke Philips N.V.
PHG
|
$ 25.35 | -0.63 % | $ 24 B | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Guardant Health
GH
|
$ 96.33 | -2.36 % | $ 12.1 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 5.71 | -1.89 % | $ 238 M | NYSE American | ||
|
Personalis
PSNL
|
$ 6.55 | -2.38 % | $ 585 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 115.8 | -1.11 % | $ 9.55 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 139.62 | -2.53 % | $ 22.2 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 52.99 | -0.01 % | $ 2.69 B | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Trinity Biotech plc
TRIB
|
$ 0.58 | -0.63 % | $ 208 M | Nasdaq Global Select Market | ||
|
Biomerica
BMRA
|
$ 2.42 | 0.41 % | $ 5.56 M | Nasdaq Capital Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 50.69 | -4.27 % | $ 3.03 B | Nasdaq Global Select Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 439.8 | -1.86 % | $ 166 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 253.87 | -0.09 % | $ 21.1 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 133.09 | -1.21 % | $ 6.22 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Waters Corporation
WAT
|
$ 329.45 | -1.15 % | $ 19.6 B | NYSE,SPB | ||
|
Neogen Corporation
NEOG
|
$ 8.39 | -0.47 % | $ 1.82 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.